Gainers
- Nkarta, Inc. (NASDAQ:NKTX) shares climbed 140.9% to close at $18.72 on Monday after the company announced Phase 1 data from independent dose finding studies of its two lead chimeric antigen receptor natural killer cell therapy candidates, NKX101 and NKX019.
- ION Geophysical Corporation (NYSE:IO) gained 46.3% to close at $0.6880 on above-average volume.
- Cango Inc. (NYSE:CANG) shares rose 40.7% to close at $3.32. Cango, last month, reported worse-than-expected Q4 EPS and sales results.
- Rubius Therapeutics, Inc. (NASDAQ:RUBY) jumped 40.6% to settle at $1.87 on above-average volume.
- ERYTECH Pharma S.A. (NASDAQ:ERYP) shares gained 37.7% to close at $1.68. Erytech Pharma recently announced publication of results from Eryapasse Phase 2 trial as treatment for hypersensitive ALL in the British Journal of Haematology.
- Redbox Entertainment Inc. (NASDAQ:RDBX) climbed 37.5% to settle at $3.92.
- Ardelyx, Inc. (NASDAQ:ARDX) climbed 31.8% to close at $0.9859 after the company reported it received an interim response from the OND, CDER and FDA for the company's second level of appeal of the Complete Response Letter for XPHOZAH.
- GWG Holdings, Inc. (NASDAQ:GWGH) jumped 31.1% to close at $2.99.
- ImmuCell Corporation (NASDAQ:ICCC) gained 29% to settle at $10.71.
- ImmuCell recently said it sees preliminary FY22 sales of $21.1 million.
- Veru Inc. (NASDAQ:VERU) gained 25.8% to close at $14.10. Veru highlighted presentation of Phase 2 Sabizabulin at the 32nd European Congress of Clinical Microbiology & Infectious Diseases.
- Sunshine Biopharma, Inc. (NASDAQ:SBFM) rose 20.4% to close at $4.01 after the company reported it filed a provisional patent application in the US covering the recently communicated mRNA molecules found in pre-clinical trials to be effective at destroying cancer cells grown in culture.
- Swvl Holdings Corp. (NASDAQ:SWVL) shares rose 18.6% to close at $7.67 after the company announced its agreement to acquire Volt Lines.
- Cabaletta Bio, Inc. (NASDAQ:CABA) jumped 18.6% to settle at $1.59.
- RiceBran Technologies (NASDAQ:RIBT) surged 18.3% to close at $0.6287.
- iCAD, Inc. (NASDAQ:ICAD) rose 18.2% to close at $3.57.
- BigBear.ai Holdings, Inc. (NASDAQ:BBAI) gained 18.1% to close at $10.10.
- AgeX Therapeutics, Inc. (NYSE:AGE) jumped 17.7% to settle at $1.00. AgeX Therapeutics, last month, reported Q4 earnings results.
- CinCor Pharma, Inc. (NASDAQ:CINC) surged 17.3% to close at $25.48.
- Aterian, Inc. (NASDAQ:ATER) climbed 16.4% to settle at $5.11.
- IT Tech Packaging, Inc. (NYSE:ITP) shares rose 16.4% to close at $0.33. IT Tech Packaging, last monthm said Q4 EPS and sales results were higher year over year.
- INmune Bio, Inc. (NASDAQ:INMB) gained 16.2% to settle at $7.96.
- Sky Harbour Group Corporation (NASDAQ:SKYH) jumped 16% to close at $9.29.
- DatChat, Inc. (NASDAQ:DATS) rose 15.7% to close at $1.99.
- Zymergen Inc. (NASDAQ:ZY) gained 15.2% to settle at $2.05.
- Dogness (International) Corporation (NASDAQ:DOGZ) gained 15.1% to close at $4.04.
- PaySign, Inc. (NASDAQ:PAYS) rose 13.5% to settle at $1.93.
- Silicon Motion Technology Corporation (NASDAQ:SIMO) gained 12.9% to close at $87.02 after Bloomberg reported that the company exploring a potential sale amid takeover interest.
- PetVivo Holdings, Inc. (NASDAQ:PETV) gained 12.7% to close at $2.22.
- PS Business Parks, Inc. (NYSE:PSB) climbed 11.8% to close at $187.50 after the company announced it will be acquired by affiliates of Blackstone Real Estate for $7.6 billion.
- Cenntro Electric Group Limited (NASDAQ:CENN) gained 10.6% to settle at $1.88 after gaining around 7% on Friday.
- BioLife Solutions, Inc. (NASDAQ:BLFS) rose 9.5% to close at $13.79. Oppenheimer upgraded BioLife Solns from Perform to Outperform and announced a $28 price target.
- Joby Aviation, Inc. (NYSE:JOBY) jumped 6.8% to close at $5.31.
- Graphite Bio, Inc. (NASDAQ:GRPH) gained 6.8% to settle at $4.27.
- Eros STX Global Corporation (NYSE:ESGC) rose 6.7% to close at $2.39.
